Security key
M47238148
Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)
CUSIP: M47238148
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Ordinary Shares, NIS 1.80 par value per share
- Shares outstanding
- 5,591,387
- Total 13F shares
- 55,876
- Share change
- +11,109
- Total reported value
- $80,439
- Price per share
- $1.44
- Number of holders
- 12
- Value change
- +$15,875
- Number of buys
- 2
- Number of sells
- 5
Report period
Q1 2025
Institutions
12
Top holders
10
GLMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M47238148
Recent filing periods:
Ownership snapshot
Top shareholders of GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Allen Baharaff
13D/G signal
Allen Baharaff
Evidence rows
12
Latest as of
31 Dec 2024
13D/G
13F
Lead comparable stake: 2.6%
13D/G row: Allen Baharaff
Showing first 8 of 12 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Allen Baharaff |
13D/G
|
2.6%
|
$60,455
44,128 shares
|
$0 | 31 Dec 2024 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
0.45%
|
$81,026
25,400 shares
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
0.22%
|
$39,971
12,530 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.12%
|
$21,440
6,721 shares
|
— | 31 Dec 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$188
59 shares
|
— | 31 Dec 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$57
18 shares
|
— | 31 Dec 2024 |
| SBI Securities Co., Ltd. |
13F
Company
|
0%
|
$51
16 shares
|
— | 31 Dec 2024 |
| Federation Des Caisses Desjardins du Quebec |
13F
Individual
|
0%
|
$45
14 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
55,876
Rows loaded
12
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
11
Q1 2025 holders
12
Holder diff
1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend